Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 278

1.

Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.

Tang M, Fenger-Eriksen C, Wierup P, Greisen J, Ingerslev J, Hjortdal V, Sørensen B.

Thromb Res. 2017 Jun;154:73-79. doi: 10.1016/j.thromres.2017.04.004. Epub 2017 Apr 5.

PMID:
28437748
2.

Temporal changes in clot lysis and clot stability following tranexamic acid in cardiac surgery.

Tang M, Wierup P, Rea CJ, Ingerslev J, Hjortdal VE, Sørensen B.

Blood Coagul Fibrinolysis. 2017 Jun;28(4):295-302. doi: 10.1097/MBC.0000000000000595.

PMID:
27607599
3.

Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.

Napolitano M, Di Minno MN, Batorova A, Dolce A, Giansily-Blaizot M, Ingerslev J, Schved JF, Auerswald G, Kenet G, Karimi M, Shamsi T, Ruiz de Sáez A, Dolatkhah R, Chuansumrit A, Bertrand MA, Mariani G.

Haemophilia. 2016 Sep;22(5):752-9. doi: 10.1111/hae.12978. Epub 2016 Jun 24.

PMID:
27338009
4.

Can Preoperative Sex-Related Differences in Hemostatic Parameters Predict Bleeding in Orthognathic Surgery?

Olsen JJ, Ingerslev J, Thorn JJ, Pinholt EM, Gram JB, Sidelmann JJ.

J Oral Maxillofac Surg. 2016 Aug;74(8):1637-42. doi: 10.1016/j.joms.2016.03.012. Epub 2016 Mar 22.

PMID:
27083576
5.

Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery.

Napolitano M, Dolce A, Batorova A, Giansily-Blaizot M, Ingerslev J, Mirbehbahani N, Di Minno MN, Lopez Fernandez MF, Karimi M, Charoenkwan P, Kavakli K, Mariani G.

Haemophilia. 2015 Nov;21(6):e513-7. doi: 10.1111/hae.12782. Epub 2015 Aug 7. No abstract available.

PMID:
26249164
6.

Prevention of Bleeding in Orthognathic Surgery--A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Olsen JJ, Skov J, Ingerslev J, Thorn JJ, Pinholt EM.

J Oral Maxillofac Surg. 2016 Jan;74(1):139-50. doi: 10.1016/j.joms.2015.05.031. Epub 2015 May 29. Review.

PMID:
26073131
7.

Improved apnea-hypopnea index and lowest oxygen saturation after maxillomandibular advancement with or without counterclockwise rotation in patients with obstructive sleep apnea: a meta-analysis.

Knudsen TB, Laulund AS, Ingerslev J, Homøe P, Pinholt EM.

J Oral Maxillofac Surg. 2015 Apr;73(4):719-26. doi: 10.1016/j.joms.2014.08.006. Epub 2014 Aug 11. Review.

PMID:
25443377
8.

Clinical phenotype in heterozygote and biallelic Bernard-Soulier syndrome--a case control study.

Bragadottir G, Birgisdottir ER, Gudmundsdottir BR, Hilmarsdottir B, Vidarsson B, Magnusson MK, Larsen OH, Sorensen B, Ingerslev J, Onundarson PT.

Am J Hematol. 2015 Feb;90(2):149-55. doi: 10.1002/ajh.23891. Epub 2014 Nov 24.

9.

Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study.

Lalezari S, Coppola A, Lin J, Enriquez MM, Tseneklidou-Stoeter D, Powell J, Ingerslev J; LIPLONG Investigators.

Haemophilia. 2014 May;20(3):354-61.

PMID:
24847524
10.

Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect.

Morfini M, Batorova A, Mariani G, Auerswald G, Bernardi F, Di Minno G, Dolce A, Fede C, Giansily-Blaizot M, Ingerslev J, Martinowitz U, Napolitano M, Pinotti M, Schved JF; International FVII [IF7] and Seven Treatment Evaluation Registry [STER] Study Groups.

Thromb Haemost. 2014 Aug;112(2):424-5. doi: 10.1160/TH13-12-1045. Epub 2014 Apr 24. No abstract available.

PMID:
24763923
11.

Inhibitors to factor VII in congenital factor VII deficiency.

Batorova A, Mariani G, Kavakli K, de Saez AR, Caliskan U, Karimi M, Pinotti M, Napolitano M, Dolce A, Sørensen B, Ingerslev J; STER Study Group.

Haemophilia. 2014 Mar;20(2):e188-91. doi: 10.1111/hae.12376. No abstract available.

PMID:
24533960
12.

Long-standing prophylactic therapy vs. episodic treatment in young people with severe haemophilia: a comparison of age-matched Danish and Russian patients.

Ingerslev J, Lethagen S, Hvitfeldt Poulsen L, Sørensen B, Lopatina E, Tentsova I, Yastrubinetskaya O, Plyushch OP.

Haemophilia. 2014 Jan;20(1):58-64. doi: 10.1111/hae.12242.

PMID:
24354479
13.

Complementary effect of fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and combined use during three deliveries.

Palsson R, Vidarsson B, Gudmundsdottir BR, Larsen OH, Ingerslev J, Sorensen B, Onundarson PT.

Platelets. 2014;25(5):357-62. doi: 10.3109/09537104.2013.819971. Epub 2013 Aug 2.

PMID:
23909788
14.

Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohort.

Hampshire DJ, Abuzenadah AM, Cartwright A, Al-Shammari NS, Coyle RE, Eckert M, Al-Buhairan AM, Messenger SL, Budde U, Gürsel T, Ingerslev J, Peake IR, Goodeve AC.

Thromb Haemost. 2013 Aug;110(2):264-74. doi: 10.1160/TH13-02-0135. Epub 2013 May 23.

15.

Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).

Napolitano M, Giansily-Blaizot M, Dolce A, Schved JF, Auerswald G, Ingerslev J, Bjerre J, Altisent C, Charoenkwan P, Michaels L, Chuansumrit A, Di Minno G, Caliskan U, Mariani G.

Haematologica. 2013 Apr;98(4):538-44. doi: 10.3324/haematol.2012.074039. Epub 2013 Feb 12.

16.

Platelet activation and aggregation: the importance of thrombin activity--a laboratory model.

Jensen MS, Larsen OH, Christiansen K, Fenger-Eriksen C, Ingerslev J, Sørensen B.

Haemophilia. 2013 May;19(3):403-8. doi: 10.1111/hae.12099. Epub 2013 Feb 6.

PMID:
23387870
17.

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.

Eikenboom J, Federici AB, Dirven RJ, Castaman G, Rodeghiero F, Budde U, Schneppenheim R, Batlle J, Canciani MT, Goudemand J, Peake I, Goodeve A; MCMDM-1VWD Study Group.

Blood. 2013 Mar 21;121(12):2336-9. doi: 10.1182/blood-2012-09-455089. Epub 2013 Jan 24.

18.

Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.

Mariani G, Napolitano M, Dolce A, Pérez Garrido R, Batorova A, Karimi M, Platokouki H, Auerswald G, Bertrand AM, Di Minno G, Schved JF, Bjerre J, Ingerslev J, Sørensen B, Ruiz-Saez A; Seven Treatment Evaluation Registry; International Factor VII Deficiency Study Group.

Thromb Haemost. 2013 Feb;109(2):238-47. doi: 10.1160/TH12-07-0476. Epub 2012 Dec 13.

PMID:
23238632
19.

Progression of haemophilic arthropathy in children: a Lithuanian--Danish comparative study.

Saulyte Trakymiene S, Clausen N, Poulsen LH, Ingerslev J, Rageliene L.

Haemophilia. 2013 Mar;19(2):212-8. doi: 10.1111/hae.12058. Epub 2012 Nov 20.

PMID:
23167920
20.

Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.

Larsen OH, Stentoft J, Radia D, Ingerslev J, Sørensen B.

Br J Haematol. 2013 Jan;160(2):228-36. doi: 10.1111/bjh.12118. Epub 2012 Nov 15.

PMID:
23151086

Supplemental Content

Loading ...
Support Center